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ABSTRACT
Chtop (chromatin target of Prmt1) regulates var-
ious aspects of gene expression including tran-
scription and mRNA export. Despite these impor-
tant functions, the regulatory mechanism underly-
ing Chtop expression remains undetermined. Using
Chtop-expressing human cell lines, we demonstrate
that Chtop expression is controlled via an autoregu-
latory negative feedback loop whereby Chtop binds
its own mRNA to retain intron 2 during splicing; a
premature termination codon present at the 5′ end
of intron 2 leads to nonsense-mediated decay of the
mRNA. We also show that Chtop interacts with exon
2 of Chtop mRNA via its arginine-glycine-rich (RG)
domain, and with intron 2 via its N-terminal (N1) do-
main; both are required for retention of intron 2. In
addition, we show that hnRNP H accelerates intron
2 splicing of Chtop mRNA in a manner dependent
on Chtop expression level, suggesting that Chtop
and hnRNP H regulate intron 2 retention of Chtop
mRNA antagonistically. Thus, the present study pro-
vides a novel molecular mechanism by which mRNA
and protein levels are constitutively regulated by in-
tron retention.
INTRODUCTION
Chtop, the chromatin target of protein arginine methyl-
transferase (PRMT) 1, localizes mainly in nuclear speckles
and tightly associates with facultative heterochromatin in
vertebrate interphase cells (1,2). As indicated by its alterna-
tive names SRAG (small protein rich in arginine and glycine
(RG)) (3) and FOP (Friend of PRMT1), Chtop has an RG-
rich domain, which is methylated by PRMT1 (1). Chtop is
expressed in a variety of tissues and cell types and is highly
conserved in all vertebrates, although no ortholog has been
identified in yeast, worm or fly.
Chtop is involved in activation of estrogen–receptor tar-
get genes (1) and in the downregulation of fetal  -globin
during the developmental transition from fetal to adult
hemoglobin (4). Chtop is therefore a potential therapeutic
target for -thalassemia and sickle cell disease via its ability
to regulate  -globin gene expression (4,5).
Chtop is also involved in mRNA export as a compo-
nent of the TREX complex (2,6,7); it drives remodeling
of this complex during mRNP (mRNA-ribonucleoprotein
complex) formation for mRNA export through its abil-
ity to bind the pre-mRNA splicing factor Uap56, which
activates both its ATPase and RNA helicase activities.
Methylation of an arginine residue in Chtop is required
for this process (6). In addition, Chtop is recruited to 5-
hydroxymethylcytosine-containing DNA sequences, which
are common in glioblastoma cells and required for tu-
morigenicity (8). Chtop also promotes PRMT1-mediated
methylation of arginine 3 of histone H4, resulting in acti-
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vation of many cancer-related genes (8). For these reasons,
Chtop is a potential therapeutic target for certain cancers
including glioblastoma.
Finally, Chtop is a component of the nuclear SMN (sur-
vival of motor neuron protein) complex that contains U5
and U6 but lacks U1 and U2 small nuclear RNAs (snR-
NAs) (9). Chtop is required for association of the SMN
complex with heterogeneous nuclear RNPs (hnRNPs), his-
tones and various RNA-binding proteins (9). Despite accu-
mulating evidence that Chtop is involved in various aspects
of gene expression, the underlying mechanism by which the
expression level of Chtop itself is regulated remains undeter-
mined. Here, we show that Chtop, by binding to exon 2 and
intron 2 of its own mRNA, controls its protein level by neg-
atively affecting the splicing of its own pre-mRNA. This, in
turn, facilitates the formation of an intron 2 (Int2)-retained
Chtop mRNA that is subsequently degraded via nonsense-
mediated mRNA decay (NMD).
MATERIALS AND METHODS
RNA Isolation and RT-PCR
Total RNA from the cells was isolated using TRIzol reagent
(Invitrogen) according to the manufacturer’s instructions.
A total of 5 g RNA was treated with three units of
Baseline-ZERO DNase (Epicentre Biotechnologies) for 1
h at 37◦C, and purified using TRIzol reagent. NanoDrop
ND-1000 Spectrophotometer (Nano-Drop Technologies,
Wilmington, USA) was used to estimate concentration and
the RNA purity (A260/A280 ratio > 1.8). Electrophore-
sis on denaturing 8M urea PAGE was run to check for
RNA degradation. For reverse transcription coupled quan-
titative PCR (RT-qPCR), first-strand cDNA was reverse-
transcribed with random hexamers and oligo d(T) using the
PrimeScript RTReagent kit (Takara, Japan). RT-qPCRuti-
lized SYBR premix, Ex Taq ll DNA polymerase (Takara)
and the Thermal Cycler Dice Real Time System (Takara)
according to themanufacturer’s instructions. TheCT values
were obtained using second derivative maximum methods
(Thermal Cycler Dice Real Time System, Takara). Relative
gene expression was determined by theCTmethod, and
values were normalized to the value obtained for GAPDH
mRNA.ForRT-PCR, cDNAwas generatedwith oligo d(T)
using PrimeScript II RT reagents (Takara), and PCR was
then performed using KOD-Plus-Neo (TOYOBO, Japan)
or Ex Taq II DNA polymerase. Amplified DNA was sub-
jected to 1% agarose gel electrophoresis, stained with ethid-
iumbromide and signals were detectedwith an ImageQuant
LAS4000 (Fujifilm) and quantified by MultiGauge soft-
ware (Fujifilm). Supplementary Table S1 lists sequences of
primers used in this study.
RNAi
RNAi (siRNA/scRNA; Invitrogen) or MISSION RNAi
(siRNA/control RNA; Sigma) transfection was performed
using Lipofectamine RNAiMAX (Life Technologies). In
35-mm Petri dishes, 5 × 105 of 293T cells were transfected
with 5 l Lipofectamine RNAiMAX and 100 pmol RNA.
Supplementary Table S1 lists each RNA sequence.
Transfection for the in vivo splicing assay
Transfection of FLAG-Chtop pcDNA5FRT/TO (minigene
for splicing assay), GFP minigene and HA-DsRed2 into
293T cells (cultured on a 35-mm collagen-coated Petri dish)
was performed using Lipofectamine 2000 (Life Technolo-
gies). After 24 h of transfection, cells were harvested and
extracts subjected to Western blotting or RT-PCR analysis.
In vitro splicing assay
To prepare a pre-mRNA substrate (biotin-labeled Ex2-
(Int2-1)-Ex3) for in vitro splicing assay, we amplified aDNA
fragment with Ex1-(Int2)-Ex4-GFP minigene as a template
using a primer set,MluI-4244-for and 3138-MluI-rev (Sup-
plementary Table S1), digested the PCR product with MluI
and self-ligated with T4 DNA ligase. Using the resultant
vector (Int2-2/Int2-3 minigene) as a template, the re-
gion corresponding to Ex2-(Int2-1)-Ex3 (2591-3138/4244-
4388) was amplifiedwith a primer set, T7-Ex2-for and 4388-
rev (Supplementary Table S1), separated by 1% agarose gel
electrophoresis and extracted from the stained gel band us-
ing the QIAquick Gel Extraction kit. Biotin-labeled Ex2-
(Int2-1)-Ex3 was transcribed from the extracted DNA tem-
plate (0.25 pmol) in the presence of 10 mM of Ribo m7G
CapAnalog (Promega), 5mMofATP, 5mMof CTP, 5mM
of UTP, 0.5 mM GTP, 0.5 mM of biotin-UTP (Roche) us-
ing CUGA R© 7 in vitro transcription kit (NIPPON GENE,
Japan) and purified by denaturing (8M urea) PAGE and
subsequent gel extraction.
DAP-Chtop and DAP-Lyar (a negative control) were
pulled down with 100 l of Ni-NTA (Qiagen) in 8 ml
xTractor buffer (Clontech) containing 1% (v/v) Empigen-
BB (SIGMA) from T-Rex 293 cells (1.0 × 108 cells) ex-
pressing DAP-Chtop (9), and DAP-Lyar (10) after induc-
tionwith doxycycline for 24 h, respectively. The pulled down
DAP-tagged proteins were purified further with 100 l of
FLAG-M2 agarose (SIGMA) using a solution containing
50mMTris-HCl pH7.4, 150mMNaCl, 0.5% IGEPALCA-
630 and 1% Empigen-BB, dialyzed in buffer D (20 mM
Hepes (pH7.9), 100 mM KCl, 0.2 mM EDTA, 20% Glyc-
erol, 1 mMDTT) for over 12 h, and used for in vitro splicing
assay.
In vitro splicing assay was performed as described (11),
with some modification. In vitro splicing reaction was car-
ried out at 30◦C for 0–180 min in a solution containing 4 l
of HeLa nuclear extract (Promega) in 15 l buffer D con-
sisting of 25 fmol of biotin-labeled ChtopmRNA described
above, 20 mM Hepes (pH7.9), 0.5 mM ATP, 20 mM crea-
tine phosphate, 3.2 mM MgCl2, 0.4 U/l RNase inhibitor
(Promega), 2.7% (w/v) polyvinyl alcohol (SIGMA) and ei-
ther DAP-Chtop or DAP-Lyar. The reaction volume was
set to 25 l. The splicing reaction was stopped by adding
300 l of TRIzol reagent, and RNA was extracted accord-
ing to the manufacturer’s instructions. The biotin-labeled
(BT) RNA was separated by denaturing (8M urea) 6%
PAGE and detected by ImageQuant LAS4000 after binding
to stabilized Streptavidin-HRP Conjugate (Thermo Scien-
tific, 89880D).
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Northern blotting
Denaturing 8M urea-PAGE of RNA and subsequent
Northern blotting were performed as described by Izu-
mikawa et al. (9). A Biotinylated (BT)-oligonucleotide
(5′-GACTATATTGCAAGTCGTCACGGC-3′) probe was
used to detect U4 snRNA (12).
Synthesis of BT-RNA
The template DNAs for in vitro transcription of Int2-1,
Int2-2, Int2-3, Int2-1-2-1, Int2-1-2-2, Int2-1-2-2a, Int2-1-
2-2b and Int2-1-2-2pSL RNA were amplified with KOD-
Plus-Neo DNA polymerase using the Ex1-(Int2)-Ex4-GFP
minigene as a template for Int2-1, Int2-2, Int2-3, Int2-1-
2-1, Int2-1-2-2, Int2-1-2-2a and Int2-1-2-2b and Int2pSL
for Int2-1-2-2pSL, respectively. Supplementary Table S1
lists the primer sets. Amplified DNA was separated by 1%
agarose gel electrophoresis and purified from gel pieces us-
ing the QIAquick Gel Extraction kit. In vitro transcription
was performed with 0.2 pmol of the template DNA using
CUGA R© 7 in vitro transcription kit (NIPPON GENE).
Transcripts were collected with the RNeasy Mini kit (Qi-
agen) (Int2-1, Int2-2, Int2-3) or isopropanol precipitation
(Int2-1-2-1, Int2-1-2-2, In2-1-2-2a, Int2-1-2-2b, Int2-1-2-
2pSL) and purified using reverse-phase liquid chromatog-
raphy. Biotin (BT) was added to the 5′ end of RNA using
the 5′ EndTag Nucleic Acid End Labeling System and Bi-
otin (Long Arm) Maleimide (Vector Labs). BT-RNA was
collected by ethanol precipitation.
RNA–protein binding assay
Nuclear extract from 1.0 × 107 cells expressing FLAG-
Chtop was used for this assay. BT-RNA (1 pmol) was
added to the extract and subjected to immunoprecipita-
tion using anti-FLAG magnetic beads as described in Sup-
plementary Data. RNA isolated from FLAG-tagged pro-
tein complexes was subjected to denaturing urea-PAGE
and Northern blotting (9,12). BT-RNA was detected with
stabilized Streptavidin-HRP Conjugate (Thermo Scientific,
89880D). Chemiluminescence was detected with an Image-
Quant LAS4000.
Expression of TF-N1
To construct HA-N1-pcDNA3.1, a DNA fragment of HA-
N1 was amplified using KOD-Plus-Neo DNA polymerase
with FLAG-Chtop pcDNA5FRT/TO as a template. The
amplified DNA was inserted at the KpnI/XhoI site of
pcDNA3.1 to produce HA-N1-pcDNA3.1. To construct
N1-pCold TF DNA, a DNA fragment of HA-N1 was gen-
erated by digestion of HA-N1-pcDNA3.1 with KpnI/XbaI
and the fragment inserted at the KpnI/XbaI site of pCold
TFDNA (Takara). TF-N1was expressed inEscherichia coli
Rosetta2 (DE3) via a 24-h induction at 15◦C in the presence
of 0.1 mM isopropyl -D-1-thiogalactosylparanoside. Cells
were extracted with xTractor Buffer (Clontech), and TF-N1
was pulled down using TALONMagnetic Beads (Life Tech-
nologies). The eluted solution containing TF-N1 was dia-
lyzed with Tris-buffered saline for 6 h at 4◦C, and purified
TF-N1was quantified with the BCA protein assay (Thermo
Scientific).
Electrophoretic Mobility Shift Assay
Each binding reaction was performed at room temperature
for 20 min. Each reaction was performed in 10 l bind-
ing buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 10
g of yeast tRNA (Ambion), 1 pmol of BT-RNA, 100 ng
of recombinant protein) and electrophoresed on a 6% non-
denaturing polyacrylamide gel at 100 V for 120 min in 0.5
× Tris borate/EDTA buffer (44.5 mM Tris-borate and 1
mM EDTA). The separated RNA–protein complexes were
transferred to a Hybond N+ membrane that was dried and
UV-crosslinked using the FS-1500 crosslinker (Funakoshi)
at 120 mJ/cm2. The BT-RNA was detected using stabilized
Streptavidin-HRP conjugate and visualized with an Image-
Quant LAS4000.
RESULTS
Exogenous expression of Chtop reduces its endogenous pro-
tein level
Using aHEK293 cell line that could inducibly express a sin-
gle copy of the FLAG-tagged Chtop (FLAG-Chtop) trans-
gene (T-REx 293 cell) (9,12–14), we confirmed that doxycy-
cline (Dox) induced FLAG-Chtop expression (Supplemen-
tary Figure S1A), and FLAG-Chtop localized to nuclear
speckles coinciding with the speckle marker SC35 (Sup-
plementary Figure S1B) (2). Western blotting revealed that
FLAG-Chtop expression decreased the level of endogenous
Chtop over time, i.e. ≥50% decrease after 48 h compared
with uninduced cells, whereas the level of FLAG-Chtop in-
creased steadily, leveling off after 24 h (Figure 1A). This de-
crease in endogenous Chtop correlated with a decrease in its
endogenous mRNA level as measured by RT-qPCR (Fig-
ure 1B). The endogenous Chtop mRNA level was reduced
upon induction of FLAG-Chtop for 48 h compared with
uninduced cells, whereas induction did not affect the level of
endogenous Chtop mRNA in T-REx 293 cells that did not
carry the FLAG-Chtop transgene (Figure 1B). In contrast,
total Chtop mRNA including exogenous Chtop mRNA in-
creased >15-fold after 48 h induction compared with unin-
duced cells (Figure 1B). These results suggested that the ob-
served reduction in the level of endogenous Chtop upon the
exogenous expression of FLAG-Chtop is caused by an au-
toregulatory mechanism at the mRNA level.
Exogenous expression of Chtop causes intron 2 retention in
Chtop mRNA
The levels of several proteins such as the splicing factors
ASF/SF2 (15), polypyrimidine tract–binding protein (PTB)
(16), hnRNP L (17) and the fragile X mental retardation
1 protein (18) are modulated via regulation of alternative
splicing of their pre-mRNAs, and therefore we examined
whether the level of alternatively spliced Chtop mRNA
changed upon the expression of FLAG-Chtop in T-REx
293 cells. We performed RT-PCR of Chtop mRNA with a
primer set amplifying regions covering exon 1 (Ex1) to Ex6
(Ex1-Ex6) (Figure 2A) and detected DNA bands of∼2000,
∼3500 and ∼7000 bp (Figure 2B, asterisks). Although the
exon/intron makeup of the 7000-bp DNA fragment could
not be determined, the 2000-bp DNA corresponded to the
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Figure 1. Exogenous Expression of FLAG-Chtop Represses the Expres-
sion of Endogenous Chtop. (A) Dox-induced expression of FLAG-Chtop.
Whole-cell extracts were subjected to Western blotting with anti-Chtop
(KT64) to reveal FLAG-Chtop and endogenous Chtop. Lamin B was used
as a loading control. (B) Schematic representation of endogenous Chtop
(NM 015607) and FLAG-Chtop mRNA. Double-headed arrows indicate
the mRNA coding sequence (CDS: 705–940) (black) and the 3′ untrans-
lated region (3′ UTR: 1138–1322) amplified by RT-qPCR. Endogenous
ChtopmRNAand total Chtop (EndoChtop+FLAG-Chtop) mRNAwere
measured by RT-qPCRwith primer sets specific for the 3′ UTR or CDS of
Chtop mRNA in T-REx 293 or FLAG-Chtop cells with (+Dox) or with-
out (–Dox) Dox. Each value of Chtop mRNA was normalized by that of
GAPDH mRNA, and relative Chtop mRNA levels were scaled to those
without Dox treatment. Data represent the mean ± SEM of three inde-
pendent experiments. P -values were calculated using the unpaired t-test.
size of Ex1-Ex6 without introns. The 3500-bp DNA frag-
ment suggested the inclusion of intron 2 (Int2, i.e. 2163 +
1641 = 3804) or Int5 (2163 + 1699 = 3862) in addition to
Ex1-Ex6. We subjected the DNAs to direct sequencing and
confirmed that the 2000-bp DNA fragment had the intron-
less sequence Ex1-Ex6 (Supplementary Figure S2A) and
that the 3500-bp DNA fragment contained Int2 (Supple-
mentary Figure S2B); we therefore denoted this DNA as
Ex1-(Int2)-Ex6. We noted that Int2 contained an in-frame
stop codon at its 5′ end (Supplementary Figure S2B).
Dox induction of FLAG-Chtop after 48 h increased
the amount of Ex1-(Int2)-Ex6 and reduced that of Ex1-
Ex6, and the percent spliced in (PSI) values of Ex1-(Int2)-
Ex6 increased ∼4-fold relative to that without Dox treat-
ment (Figure 2B). Using two other primer sets to am-
plify regions covering Ex1-Ex4 and Ex4-Ex6, we con-
firmed that FLAG-Chtop induction increased the PSI val-
ues of the 2000-bp Ex1-(Int2)-Ex4 band, and reduced the
PSI values of the 600-bp (Ex1-Ex4) and 1000-bp (Ex4-
Ex6) bands (Supplementary Figure S2C). The increase
of Ex1-(Int2)-Ex4 was detected in both the cytoplasmic
and the nuclear fractions prepared by cell fractionation
of the FLAG-Chtop induced cells (Supplementary Figure
S2D), indicating that Int2-retained Chtop mRNA is deliv-
ered to the cytoplasm. A methyltransferase inhibitor (5′-
methylthioadenosine, MTA) did not show any effect on
Int2-retention of Chtop mRNA (Figure 2C). Since methy-
lation of an arginine residue in Chtop is required for its role
in the TREX complex, this suggests that the cytoplasmic
localization of Int2-retained Chtop mRNA is not linked to
the TREX complex (6).
To investigate Int2 retention further, we constructed a
minigene containing Ex1-(Int2)-Ex4 positioned upstream
of the GFP-coding DNA (wild-type Ex1-(Int2)-Ex4-GFP
mini gene) (Supplementary Figure S2E). By using this
minigene in which Int2 was the only intron, we moni-
tored Int2 retention by RT-PCR with a primer set span-
ning Ex1 to GFP (Supplementary Figure S2E). In this
analysis, the proportion of Ex1-(Int2)-Ex4-GFP increased
with increasing FLAG-Chtop level compared with cells
lacking FLAG-Chtop expression (Supplementary Figure
S2F). In addition, the Chtop knockdown reduced the PSI
value of Int2-retained transcript compared with that mea-
sured for cells transfectedwith scrambled/nonspecificRNA
(scRNA) (Supplementary Figures S2G and S2H). We also
used the E1A minigene (19) to distinguish between splicing
inhibition and regulated alternative splicing, and showed
that the increase of Chtop expression did not affect splic-
ing of thisminigene (SupplementaryFigure S2I), suggesting
that Chtop causes Int2 retention of Chtop mRNA as regu-
lated alternative splicing. Collectively, these data strongly
suggested that Chtop promotes Int2 retention during splic-
ing of Chtop mRNA.
Chtop auto-regulates its expression by nonsense-mediated
mRNA decay
Given the fact that a stop codon is present within Chtop in-
tron 2, we predicted that the Int2-retained Chtop mRNA
would be degraded by NMD (20). We therefore assessed
the effect of the translation inhibitor cycloheximide, which
also inhibits NMD (21), on Int2 retention in T-REx 293
cells expressing FLAG-Chtop. In agreement with our pre-
diction, cycloheximide increased the level of Int2-retained
ChtopmRNA in both FLAG-Chtop and control cells (Fig-
ure 3A). We also assessed the effect of siRNA-mediated
knockdown of UPF1 (an essential component of the NMD
machinery) (22) on Int2 retention, revealing that UPF1
knockdown increased Int2 retention (Figure 3B). In addi-
tion, using the Ex1-(Int2)-Ex4-GFP minigene, we showed
that the amount of GFP protein decreased with increased
FLAG-Chtop expression (Supplementary Figure S3). Col-
lectively, these data support the notion that Int2-retained
Chtop mRNA is degraded via NMD.
Both the N-terminal domain (N1) and RG-rich domain of
Chtop are required for Int2 retention
To examine the mechanism by which Chtop causes Int2 re-
tention during Chtop mRNA splicing, we first determined
the region in Chtop responsible for Int2 retention. We pre-
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Figure 2. Chtop Causes Int2 Retention. (A) Schematic representation of Chtop gene. Exons (Ex, boxes) and introns (Int, lines) are indicated. Gray boxes
denote non-coding regions in Ex1, Ex2 or Ex6. The sequence length is indicated under each exon and intron. Primers (arrows) and the PCR-amplified
region (dotted line) are shown. (B) RT-PCR ofChtopmRNAupon FLAG-Chtop expression. DNA fragments (*, **, ***) were amplified from endogenous
Chtop mRNA by using a primer set specific for Ex1 to Ex6 (Ex1-Ex6) of Chtop mRNA before (−) and 24 h after (+) Dox induction of T-REx 293 cells
expressing FLAG-Chtop (left). T-REx 293 cells lacking FLAG-Chtop expression were used as control cells. ACTBmRNA was used as a loading control.
The bar graph shows the percent spliced in (PSI) values of the ∼3500-bp DNA fragment (**) in total cDNA (right). Data represent the mean ± SEM of
three independent experiments. The P-value was calculated with the unpaired t-test. (C) Effect of methyltransferase inhibitor on Int2 retention induced
by Chtop overexpression. T-REx 293 cells expressing FLAG-Chtop were treated with (+) or without (−) 5′-deoxy-5′-methylthio-adenosine (MTA) for
24 h after induction (+) or not (–) with Dox for 24 h. Chtop protein (left) was detected by Western blotting with the indicated antibodies, and the DNA
fragments (right) were detected with RT-PCR with the indicated primer sets.
pared additional Dox-inducible T-REx 293 cell lines ex-
pressing various deletion mutants of Chtop (C1, RG,
N1 or NLSN1), each containing an N-terminal FLAG
tag (Figure 4A). When the four mutants were individually
expressed in T-REx 293 cells (Figure 4B), onlyC1 reduced
the proportion of endogenous Chtop mRNA (Supplemen-
tary Figure S4A). Conversely, C1 increased the propor-
tion of the Int2-retained transcript (indicated as Ex1-(Int2)-
Ex4 in Figure 4C). By contrast,RG did not cause Int2 re-
tention although the mutant protein localized mainly to the
nucleus (Figure 4C, Supplementary Figure S4B). In addi-
tion to this result, expression of N1 and NLSN1, which
contain the RG domain, did not result in Int2 retention de-
spite of the nuclear localization of NLSN1 (though N1
seemed to be dispersed throughout the cell) (Supplementary
Figure S4B). Consistent with these results, C1 decreased
the endogenous Chtop level, but the other mutants did not
(Figure 4B). Collectively, these experiments suggest that the
RG and N1 domains are both required for Int2 retention.
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Figure 3. Int2-retained Chtop mRNA is degraded via NMD. (A) RT-PCR of Chtop mRNA upon cycloheximide (Chx) treatment. After Dox-mediated
induction of FLAG-Chtop cells for 48 h, cells were treated with Chx for 2 h. ChtopmRNA was analyzed by RT-PCR with a primer set specific for Ex1 to
Ex6 (Ex1-Ex6) of Chtop mRNA. Ex1-Ex6 and Ex1-(Int2)-Ex6 are indicated to the right of the figure. ACTB mRNA was used as a loading control. Bar
graph shows the PSI values of Ex1-(Int2)-Ex6 mRNA. Data represent the mean ± SEM of three independent experiments. The P-values were calculated
with the unpaired t-test. (B) RT-PCR of Chtop mRNA upon UPF1 knockdown. siRNA-mediated UPF1 knockdown in 293T cells is shown by Western
blotting (left). -actin was used as a loading control. Chtop mRNA in UPF1-knockdown cells was analyzed by RT-PCR with a primer set specific for
Ex1-Ex6 of Chtop mRNA (middle). ACTB mRNA was used as a loading control. The bar graph reports the PSI values of Ex1-(Int2)-Ex6 mRNA. Data
represent the mean ± SEM of three independent experiments. The P-values were calculated with the unpaired t-test.
Ex2 and 5′-region of intron 2 in ChtopmRNA are involved in
intron 2 retention
To determine the region in Chtop mRNA that is involved
in Int2 retention, we constructed a series of Ex1-(Int2)-
Ex4-GFP minigenes that lacked Ex1 (56-362)(Ex1), Int2-
1 (2697-3138) (Int2-1), Int2-2 (3139-3970) (Int2-2) or
Int2-3 (3971-4243) (Int2-3) (Supplementary Figure S5A).
All of the minigenes tested displayed increased Int2 re-
tention upon increased expression of Chtop (Supplemen-
tary Figure S5B). Next, we constructed minigenes in which
two regions of Ex1-(Int2)-Ex4-GFP were altered by com-
bination of deletion and replacement; i.e. Ex1-2/Int2-
1 had a replacement of Ex1 and Ex2 by Ex2 of the INS2
gene and a deletion of Int2-1, Ex1-2 had replacement
of Ex1 and Ex2 by Ex2 of the INS2 gene, Ex1/Int2-
1 had deletions of Ex1 and Int2-1, and Ex2/Int2-1
had a replacement of Ex2 by Ex2 of the INS2 gene and a
deletion of Int2-1 (Figure 5A). Of these minigenes, Ex1-
2/Int2-1 and Ex2/Int2-1 did not display Int2 reten-
tion upon increasedChtop expression, whereasEx1-2 and
Ex1/Int2-1 did retain Int2 upon increased Chtop ex-
pression (Figure 5B). Collectively, these data suggest that
Chtop Ex2 and Int2-1 are directly involved in Int2 reten-
tion of Chtop mRNA, and thus are responsible for auto-
regulation of Chtop expression.
Based on these results, we synthesized an RNA contain-
ing the Int2-1 sequence between Ex2 and Ex3 (Ex2-(Int2-
1)-Ex3), and used it as a substrate for an in vitro splicing
assay to examine the effect of Chtop on Int2 splicing. The
addition of purifiedChtop increased the proportion of Int2-
retained substrate when compared with reactions carried
out in the absence of purified Chtop (Figure 5C), suggesting
that Chtop regulates Int2 splicing directly.
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Figure 4. The N1 and RG regions of Chtop are responsible for Int2 Retention. (A) Schematic representation of the Chtop deletion mutants C1, RG,
N1 and NLSN1. FL: FLAG; NLS: Nuclear localization signal. (B) Mutant-expressing cells were induced with Dox for 48 h, and endogenous Chtop
was analyzed by Western blotting with the antibodies indicated at the bottom of each blot (KT59, KT64). Each Chtop deletion mutant is indicated by
‘FLAG’ (closed arrowhead), and endogenous Chtop by open arrowhead. -actin was used as a loading control. (C) RT-PCR of Chtop mRNA in Dox-
inducible Chtop deletion-mutant cells. Each of the mutant cells was treated with Dox for 48 h, and ChtopmRNA was analyzed by RT-PCR with a primer
set specific for Ex1 to Ex4. Ex1-(Int2)-Ex4 and Ex1-Ex4 of Chtop mRNA are indicated to the right of the figure. ACTB mRNA was used as a loading
control.
N1 and RG domains bind Ex2 and putative stem loop region
of Int2 in Chtop mRNA
Given that Chtop binds Int2-retained Chtop mRNA in
vivo as determined by a combination of pulldown and RT-
PCR analyses (Supplementary Figure S6A), we examined
whether Chtop interacts with Ex2 and Int2-1 regions of
Chtop mRNA. Since Ex2 has a relatively small length of
81 nucleotides, we synthesized a biotin labeled-RNA con-
taining the entire region of Ex2 (BT-Ex2), and examined
its binding to each of the Chtop domain mutants (C1,
RG or NLS-N1) by RNA–protein binding assay. This
assay indicated that the RG domain is responsible for the
binding to Ex2 (Figure 6A). Int2-1 has a length of 441
nucleotides, so we divided Int2-1 into two regions to syn-
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Figure 5. The Ex2 and Int2-1 region of Chtop mRNA is responsible for Int2 retention. (A) Schematic representations of Ex1-(Int2)-Ex4-GFP and its
mutant minigenes constructed for in vivo splicing assays. Each Exon (Ex) and Intron (Int) of Chtop or Ex2 of INS2 mRNA is shown. Nucleotide residue
numbers corresponding to those of CHTOP gene (NG 030030.1) are shown on top of the figure. Primers (arrows) used for in vivo splicing assay are shown.
(B) In vivo splicing assay using Ex1-(Int2)-Ex4-GFP and its deletion mutant minigenes with (+) and without (−) FLAG-Chtop expression. The PSI values
of Int2 retained mRNA are shown under each of the figures. Data represent the average (Ave.) ± SEM of at least three independent experiments. The
P-values were calculated with the unpaired t-test. (C) In vitro splicing assay using Ex2-(Int2-1)-Ex3 RNA in the presence of DAP-Chtop (+Ch) or DAP-
Lyar (+Ly). The purified Ch and Ly were separated by SDS-PAGE and detected by CBB staining (Left). Ex2-(Int2-1)-Ex3 RNA was incubated with the
nuclear extract of HeLa cells in the presence (200 ng) or absence of Ch or Ly for the indicated time periods. Overexposed picture is shown at the right side.
Unspliced form and spliced form are indicated. Relative band intensities of spliced form in lane 4–6 were indicated in the graph. Data represent the average
(Ave.) ± SEM of four independent experiments. The P-values were calculated with the paired t-test (**P < 0.01).
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Figure 6. Identification of Chtop domains responsible for binding to ChtopmRNA. (A and B) RNA–protein binding assay. (A) BT-Ex2 or (B) BT-Int2-1-
2-2 was incubated with the nuclear extracts of T-REx 293 cells (control; TR) or T-REx 293 cells expressing wild type (WT), C1,RG,N1 or NLSN1
mutant with (+) or without (−) Dox induction, immunoprecipitated with anti-FLAG magnetic beads, and detected by Northern blotting. FLAG-tagged
proteins were detected by Western blotting (arrowhead). IgG light chain of anti-FLAG antibody was also detected as shown by asterisk (loading control).
(C) Electrophoretic mobility shift assay (EMSA) was performed using recombinant TF-N1 (or control TF) with BT-Int2-1-2-1 or BT-Int2-1-2-2pSLRNA.
(D) In vivo splicing assay using Ex1-(Int2)-Ex4-GFP, Int2-1-2-2 or Int2pSL minigene. PCR using reverse-transcribed RNA. (-RT) was used as a control
of RT-PCR (+RT). The PSI values of unspliced form are shown under the figure. Data represent the average (Ave.) ± SEM of at least three independent
experiments. The P-values were calculated with the unpaired t-test (**P < 0.01).
thesize their corresponding RNAs, taking the highly con-
served regions of the Int2 sequence inChtopmRNA among
100 vertebrates into account (UCSC Genome browser;
http://genome.ucsc.edu/) (Supplementary Figure S6B and
S6C). The synthesized BT-RNAs (BT-Int2-1-1 and BT-
Int2-1-2) corresponded to the following regions of Chtop
mRNA: 2668–2873 (206 nucleotides) and 2893–3169 (277
nucleotides), respectively (Supplementary Figure S6B and
S6C). A third BT-RNA, BT-Int2-3, was also synthesized
as a negative control representing a region not responsi-
ble for Int2 retention (3971–4314, 344 nucleotides) (Supple-
mentary Figure S6B). The RNA–protein binding assay in-
dicated that Chtop was bound tightly to BT-Int2-1-2 RNA
and very weakly to BT-Int2-1-1 RNA, whereas BT-Int2-3
did not bind Chtop at all (Supplementary Figure S6D). To
further narrow the region responsible for Chtop binding, we
synthesized two additional BT-RNAs, namely BT-Int2-1-2-
1 (2893–2994) and BT-Int2-1-2-2 (2997–3138) (Supplemen-
tary Figure S6C). The RNA–protein binding assay showed
that BT-Int2-1-2-2 was bound by FLAG-Chtop (Supple-
mentary Figure S6E).
ARNA–protein binding assay using BT-Int2-1-2-2 RNA
and extracts of T-REx 293 cells expressing Chtop mutants
(C1, RG, N1 or NLSN1) showed that BT-Int2-1-2-
2 bound to wild-type, C1, and RG but not to N1 and
NLSN1 Chtop (Figure 6B), suggesting that domain N1 is
responsible for binding Int2-1-2-2. We confirmed the direct
binding between N1 and BT-Int2-1-2-2 by electrophoretic
mobility shift assay (EMSA) using recombinantN1 domain
fused to trigger factor (TF) (Supplementary Figures S6F
and S6G). TF-N1 caused a shift of BT-Int2-1-2-2 but not
Bt-Int2-1-2-1, whereas TF alone (control) did not cause any
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Figure 7. hnRNP H promotes excision of Chtop Int2. (A) hnRNP F or hnRNP H was knocked down with its corresponding siRNA in 293T cells and
detected byWestern blotting (left). -actin was used as a loading control.ChtopmRNA in hnRNP-knockdown cells was detected byRT-PCRwith a primer
set specific for Ex1-Ex4 of Chtop mRNA (middle). ACTB mRNA was used as a loading control. The bar graph reports the PSI values of Ex1-(Int2)-Ex4
RNA (right). Data represent the mean ± SEM of three independent experiments. The P-values were calculated with the unpaired t-test. (B) FLAG-Chtop
or each of its deletion mutants was immunoprecipitated from the nuclear extract of T-REx 293 cells expressing wild type; WT, C1, RG, NLSN1 or
N1 with (+) or without (−) doxycycline (Dox) induction and analyzed by Western blotting with anti-FLAG (arrowhead) and anti-hnRNP H antibodies.
IgG light chain of anti-FLAG antibody is indicated with an asterisk. (C) Effects of FLAG-Chtop and/or HA-hnRNPH expression on Int2 retention in in
vivo splicing assay using Ex1-(Int2)-Ex4-GFPminigene (upper panel). Expression vectors for FLAG-Chtop and/or for HA-hnRNPH (+) or empty vector
(−) were transfected into 293T cells. PCR was performed using reverse-transcribed RNA (+RT); reactions lacking reverse transcriptase (-RT) were used
as controls. The PSI values of Ex1-(Int2)-Ex4-GFP are shown below. Data represent the average (Ave.) ± SEM of at least three independent experiments.
The P-values were calculated with the unpaired t-test. HA-hnRNP H or FLAG-Chtop was detected by Western blotting (bottom panel). -actin was used
as a loading control.
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Figure. 8. Proposed mechanism by which Chtop regulates Int2 Exclusion. Chtop binds to the stem-loop region in Int2 of ChtopmRNA via its N1 domain
and Ex2 via its RG region, and inhibits the excision of Int2. Int2-retained Chtop mRNA contains a stop codon at the 5′ side of Int2 and is degraded by
NMD. hnRNP H binds Int2 of Chtop mRNA and N1-RG of Chtop protein, and promotes excision of Int2. Chtop and hnRNP H regulate Int2 splicing
antagonistically.
shift (Supplementary Figure S6H). These data indicated
that Chtop, via domain N1, binds the Int2-1-2-2 region of
its mRNA.
To predict the secondary structure of the Int2-1-2-2
region, we used the RNAfold webserver (http://rna.tbi.
univie.ac.at/cgi-bin/RNAfold.cgi) (23). This analysis pre-
dicted that Int2-1-2-2 could form two stable stem-loops
(Supplementary Figure S6I). Because the sequence of re-
gion Int2-1-2-2 is highly conserved among vertebrates, we
assumed that these two predicted stem-loops are impor-
tant for binding to Chtop and for Chtop-mediated Int2 re-
tention. To further narrow the region responsible for Int2
retention, we constructed two additional Int2-containing
minigenes, Int2-1-2-2a and Int2-1-2-2b, each lacking
one of the predicted stem-loops of region Int2-1-2-2 (Sup-
plementary Figure S6J). Mutant Int2-1-2-2a decreased
the ratio of Int2-retained mRNA to unretained mRNA
by ∼40% compared with that of Ex1-(Int2)-Ex4-GFP, and
Int2-1-2-2b reduced the ratio by ∼77% (Supplementary
Figure S6K). This result indicated that each of the pre-
dicted stem-loops contributes to Int2 retention with a more
important role for Int2-1-2-2a. In agreement with this no-
tion, our RNA–protein binding assays also showed that
both BT-Int2-1-2-2a and BT-Int2-1-2-2b bound to FLAG-
Chtop, but BT-Int2-1-2-2b bound very weakly (Supple-
mentary Figure S6L). To disrupt the two predicted stem-
loop structures of region Int2-1-2-2, we synthesized a mu-
tant BT–RNA having a sequence corresponding to region
Int2-1-2-2 but containing a G-to-C switch at nine posi-
tions in the two repeat sequences in Int2-1-2-2 (BT-Int2-1-2-
2pSL) (Supplementary Figure S6I). BT-Int2-1-2-2pSL did
not bind significantly to recombinant TF-N1 as revealed
by EMSA (Figure 6C). We then constructed an Ex1-(Int2)-
Ex4-GFP minigene containing a G-to-C switch at nine po-
sitions in region Int2-1-2-2 (Int2pSL) (Figure 5A and Sup-
plementary Figure S6I). Int2pSL caused only marginal Int2
retention (Figure 6D). To assess the importance of these
mutations further, we constructed aEx1-2/Int2pSLmini-
gene in which the Ex1 and Ex2 of Chtop mRNA were re-
placed by Ex2 of INS2 mRNA and Int2-1-2-2 regions of
Chtop mRNA by Int2pSL (Figure 5A), and showed that
this construct did not cause Int2 retention (Figure 5B). Col-
lectively, these results indicate that the two predicted stem-
loops containing conserved repeat sequences in region Int2-
1-2-2 of Chtop mRNA are responsible for Chtop-mediated
Int2 retention and suggest strongly that the two regions Ex2
and In2-1-2-2 in Chtop mRNA are responsible for Int2 re-
tention via binding to the RG and N1 domain of Chtop,
respectively.
hnRNP H negatively regulates Int2 retention
Previous proteomic analysis identified a number of nu-
clear proteins that associate with Chtop, including proteins
involved in mRNA splicing and mRNA export such as
SRSF6, hnRNP F and hnRNP H (9). Because hnRNP F
and hnRNP H are reportedly involved in splicing regula-
tion (24–26), we examined the possible involvement of these
two hnRNPs in Int2 retention by using RNAi-mediated
knockdown. hnRNP H knockdown increased the propor-
tion of Int2-retained forms ∼2-fold compared with cells
treated with scRNA (control), whereas hnRNP F knock-
down did not change the proportion (Figure 7A). Consis-
tently, hnRNP H knockdown reduced the level of endoge-
nous Chtop relative to -actin when compared with con-
trol cells treated with scRNA (Figure 7A). In hnRNP H
knockdown cells, cycloheximide increased the Int2-retained
ChtopmRNA compared with control (Supplementary Fig-
ure S7A), suggesting that hnRNP H is involved in Int2
removal. In addition, the hnRNP H knockdown also in-
creased Int2-retention when using the Ex1-(Int2)-Ex4-GFP
minigene (Supplementary Figure S7B). These data suggest
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that hnRNPH promotes Int2 exclusion and thus negatively
affects Int2 retention.
To study how hnRNP H negatively impacts Int2 reten-
tion, we utilized antibody-mediated pulldown of endoge-
nous hnRNP H. Association of endogenous hnRNP H
with the Int2-retained Chtop mRNA increased in concert
with increased FLAG-Chtop expression compared with
cells lacking FLAG-Chtop expression (Supplementary Fig-
ure S7C). We did not detect association between hnRNP H
and Int2-splicedChtopmRNA (Ex1-Ex4 in Supplementary
Figure S7C) evenwithFLAG-Chtop expression. These data
suggest that hnRNP H increased its interaction with the
Int2 region of Int2-retained Chtop mRNA in conjunction
with increased Chtop expression, or that increased Chtop
interaction with its mRNA results in the detection of hn-
RNP H interaction with the mRNA. To further narrow the
region responsible for the binding of hnRNP H, we exam-
ined RNA–protein binding assay using the synthetic BT-
RNAs and showed that hnRNP H bound Int2 in the re-
gions corresponding mainly to Int2-1 and to a lesser ex-
tent to Int2-2. In contrast, hnRNP H did not have inter-
actions with BT-RNAs corresponding to Int2-3 and exon 2
of Chtop mRNA (Supplementary Figure S7D).
We next examined interaction between hnRNP H and
Chtop by pulldown analysis in combination with RNase
treatment, revealing that FLAG-Chtop associated with hn-
RNP H independently of RNA (Supplementary Figure
S7E). As a control, RNase activity was confirmed by the
disappearance of U4 snRNA. The pulldown analysis was
also carried out using the domain mutants C1, RG,
N1 and NLSN1 revealing that only C1 associated
with hnRNP H (Figure 7B). Because RG and NLSN1
localized to the nucleus (as did wild-type FLAG-Chtop and
C1) but did not interact with hnRNPH (Figure 7B), these
results suggested that the N1 and RG domains are respon-
sible for Chtop binding to hnRNP H.
Finally, we examined the effect of overexpression of hn-
RNP H on Int2 retention, and found that the Chtop-
induced Int2 retentionwas reduced by the overexpression of
hnRNP H. Since overexpression of hnRNP H as such did
not affect splicing and retention of Int2 of Chtop mRNA
in vivo (Figure 7C), we conclude that Chtop and hnRNP
H have an antagonistic effect on Int2 retention of Chtop
mRNA.
DISCUSSION
Here, we demonstrate that the cellular level of Chtop is au-
toregulated via Int2 retention of its ownmRNA,which sub-
sequently undergoes NMD.We also show that domains RG
and N1 of Chtop interact with Ex2 and the putative stem
loop structure in Int2, respectively, and that both interac-
tions are required for Int2 retention of Chtop mRNA (Fig-
ure 8). In addition, we show that hnRNP H is involved in
Int2 removal. Given that deficiency of hnRNP H increases
Int2-retained Chtop mRNA (Figure 7A), and that Chtop-
induced Int2 retention is reduced by overexpression of hn-
RNPH (Figure 7C), we suggest that Int2 retention ofChtop
mRNA is balanced by antagonistic action of Chtop and hn-
RNP H. Since Chtop and hnRNP H act on Int2 retention
and splicing independently of each other (Figure 8), the pro-
portion of Int2 retention is probably determined by the rel-
ative amount of Chtop to that of hnRNP H in the cell. In
this case, we do not exclude the possibility that Chtop asso-
ciates with hnRNPHwithout binding to regions in Ex2 and
Int2-1-2-2; this association may also suppress the ability of
hnRNPH to promote Int2 removal. Because Chtop bridges
hnRNPs, including hnRNP H and the nuclear SMN com-
plex, it is also possible that the hnRNP H–Chtop interac-
tion ismediated by the SMNcomplex (9). It would therefore
be interesting to determinewhetherChtop anchors both hn-
RNP H and the SMN complex on Int2.
A number of studies have reported negative feedback
mechanisms in which protein levels are autoregulated by
modulating alternative mRNA splicing followed by NMD
(22,27–31), but the molecular mechanisms underlying such
autoregulation have been elucidated for only a few proteins
(15–17,31). One such case is PTB, for which a high con-
centration increases its binding to intron 10 of its mRNA;
this increases exon 11 skipping, producing an mRNA that
then undergoes NMD (16). Another example is hnRNP L,
which, at high concentration, increases its binding to intron
6 of its mRNA, thereby increasing exon 6a inclusion that
also leads to NMD (17). However, these two examples of
autoregulatorymechanisms do not involve intron retention.
Intron retention is generally thought to occur because of
mis-splicing resulting in failed intron excision (32,33). Be-
cause intron-retained mRNAs often contain premature a
stop codon, they are expected to undergoNMD(20,34). Re-
cently, Wong et al. (33) reported that intron retention cou-
pled with NMD is a physiological mechanism of gene ex-
pression control in normal granulopoiesis, but the molecu-
lar mechanism by which intron retention occurs is largely
unknown. The present study provides a novel autoregu-
lation mechanism involving intron retention followed by
NMD.
Finally, because upregulation of Chtop is required for tu-
morigenicity of glioblastoma cells (8), it would be interest-
ing to investigate whether Int2 retention-coupled NMD of
ChtopmRNA is downregulated in glioblastoma cells. In ad-
dition, an increase in  -globin level mitigates the severity of
-thalassemias (because  -globin can mediate the replace-
ment of adult hemoglobin with fetal hemoglobin) and sickle
cell disease (because  -globin can counteract polymeriza-
tion of sickle hemoglobin) (35). Because Chtop is a critical
modulator of  -globin gene expression (4), Int2 retention
during splicing of Chtop mRNA may be a therapeutic tar-
get for the treatment of these two diseases.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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